Host adds to Owlet position citing FDA moat, telehealth optionality, and debt refinancing
Owlet trades at 1.6x EV/sales with revenue doubling, holds unique FDA approval for baby monitors creating a regulatory moat, and is expanding into high-margin subscription telehea…